Improvements in Intractable Lumbar and Lower-Extremity Symptoms after Systemic Administration of Tocilizumab, an Anti-interleukin-6 Receptor Antibody

STUDY DESIGN: Prospective cohort study (open-label, single-arm, and non-blinded). PURPOSE: This study aims to determine the effects of systemic administration of tocilizumab, an anti-interleukin-6 (IL-6) receptor antibody on refractory low back pain and leg symptoms. OVERVIEW OF LITERATURE: IL-6 ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Sainoh, Takeshi, Orita, Sumihisa, Miyagi, Masayuki, Suzuki-Narita, Miyako, Sakuma, Yoshihiro, Oikawa, Yasuhiro, Kubota, Go, Sato, Jun, Shiga, Yasuhiro, Fujimoto, Kazuki, Eguchi, Yawara, Koda, Masao, Aoki, Yasuchika, Akazawa, Tsutomu, Furuya, Takeo, Nakamura, Junichi, Takahashi, Hiroshi, Maki, Satoshi, Inoue, Masahiro, Kinoshita, Hideyuki, Norimoto, Masaki, Sato, Takashi, Sato, Masashi, Suzuki, Masahiro, Enomoto, Keigo, Takaoka, Hiromitsu, Mizuki, Norichika, Hozumi, Takashi, Tsuchiya, Ryuto, Kim, Geundong, Otagiri, Takuma, Mukaihata, Tomohito, Hishiya, Takahisa, Ohtori, Seiji, Inage, Kazuhide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Spine Surgery 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873999/
https://www.ncbi.nlm.nih.gov/pubmed/34015207
http://dx.doi.org/10.31616/asj.2020.0283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873999/
https://www.ncbi.nlm.nih.gov/pubmed/34015207
http://dx.doi.org/10.31616/asj.2020.0283

Ejemplares similares